Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 1, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	245,947	205,849	158,581	-	-	-
Market Cap Growth	65.22%	29.81%	-	-	-	-
Enterprise Value	247,253	206,963	166,413	-	-	-
Last Close Price	1160.00	972.00	760.85	-	-	-
PE Ratio	70.60	59.00	93.21	-	-	-
Forward PE	60.83	51.14	72.51	-	-	-
PS Ratio	11.22	9.39	9.36	-	-	-
PB Ratio	9.90	8.29	7.45	-	-	-
P/TBV Ratio	9.93	8.31	7.49	-	-	-
P/OCF Ratio	48.31	40.43	50.50	-	-	-
PEG Ratio	1.94	1.08	-	-	-	-
EV/Sales Ratio	11.28	9.44	9.82	-	-	-
EV/EBITDA Ratio	39.17	32.79	46.28	-	-	-
EV/EBIT Ratio	53.25	44.58	61.49	-	-	-
Debt / Equity Ratio	0.12	0.12	0.17	0.95	1.05	1.10
Debt / EBITDA Ratio	0.46	0.46	0.88	3.28	5.80	8.18
Debt / FCF Ratio	-	-	-	11.40	8.77	-
Net Debt / Equity Ratio	0.05	0.05	-0.01	0.76	0.82	0.85
Net Debt / EBITDA Ratio	0.21	0.21	-0.05	3.03	5.77	8.19
Net Debt / FCF Ratio	-1.56	-1.56	0.36	9.13	6.85	-7.35
Asset Turnover	0.65	0.65	0.62	0.66	0.56	0.44
Inventory Turnover	4.23	4.23	4.97	4.27	3.50	3.04
Quick Ratio	0.64	0.64	1.58	1.05	0.93	0.99
Current Ratio	1.69	1.69	2.05	1.28	1.27	1.32
Return on Equity (ROE)	15.13%	15.13%	10.96%	8.89%	1.13%	0.71%
Return on Assets (ROA)	8.55%	8.55%	6.22%	4.83%	1.90%	0.98%
Return on Invested Capital (ROIC)	13.91%	14.72%	10.57%	7.83%	2.48%	1.34%
Return on Capital Employed (ROCE)	16.60%	16.60%	11.10%	11.20%	4.60%	2.10%
Earnings Yield	1.42%	1.70%	1.07%	-	-	-
FCF Yield	-0.34%	-0.41%	-0.35%	-	-	-
Buyback Yield / Dilution	-7.47%	-7.47%	-8.04%	-0.27%	-0.46%	-5.32%